5. All paths lead to Rome: Evolutionary convergence and divergence of K+ channel blocking toxins

Toxicon ◽  
2014 ◽  
Vol 91 ◽  
pp. 166
Author(s):  
R.C. Rodríguez de la Vega ◽  
T. Giraud
1996 ◽  
Vol 39 (21) ◽  
pp. 4247-4254 ◽  
Author(s):  
Joaquin Campos Rosa ◽  
Dimitrios Galanakis ◽  
C. Robin Ganellin ◽  
Philip M. Dunn

2020 ◽  
Vol 10 (6) ◽  
pp. 409-423
Author(s):  
Laura De Giglio ◽  
Francesca Cortese ◽  
Elena Maria Pennisi

Symptomatic treatment has a great relevance for the management of patients with neurologic diseases, since it reduces disease burden and improves quality of life. Aminopyridines (APs) are a group of potassium (K+) channel blocking agents that exert their activity both at central nervous system level and on neuromuscular junction. This review describes the use of APs for the symptomatic treatment of neurological conditions. We will describe trials leading to the approval of the extended-release 4-aminopyridine for MS and evidence in support of the use in other neurological diseases.


1989 ◽  
Vol 62 (4) ◽  
pp. 984-995 ◽  
Author(s):  
J. E. Freschi ◽  
D. R. Livengood

1. We studied the effect of cholinergic agonists on motoneurons of the lobster cardiac ganglion under voltage clamp. 2. In unclamped neurons, acetylcholine (ACh) caused a depolarization and increase in burst potential frequency. By the use of nicotinic and muscarinic agonists, we determined that both types of receptors are present on the neurons. We therefore used specific muscarinic agonists to further study ionic mechanisms underlying the muscarinic cholinergic current (Imch). 3. Muscarinic agonists produced detectable inward current at doses above 10(-6) M, and maximum effect was seen at doses above 10(-3) M. 4. Imch was voltage-dependent. When the membrane holding potential was shifted to levels negative to the resting potential, the response declined, nulling but not reversing at -80 to -100 mV. The response enlarged with membrane depolarization, reaching a maximum at between -30 and -10 mV. With further depolarization, the response declined and then reversed at potentials around +20 mV. 5. The muscarinic response varied as a function of extracellular Na+ concentration and was completely blocked in Na+-free solutions. The relationship between response amplitude and external Na+ was well described by the electrodiffusion equation for Na+ driving force. 6. Imch amplitude also varied as a function of extracellular potassium concentration, becoming larger with low external K+ and smaller at higher concentrations. Shifting the Cl- equilibrium potential did not affect the properties of the Imch. 7. Tetrodotoxin (TTX) had no effect on Imch. In concentrations of 1-10 mM, such K+-channel blocking agents as Ba2+, Cs+, 4-aminopyridine (4-AP), or tetraethylammonium (TEA), and such Ca2+-channel blockers as Co2+ or Mn2+, when applied externally, did not suppress Imch. Above 30 mM, TEA did inhibit the response, and combinations of K+-channel blocking agents, each at concentrations insufficient alone to block the current, also inhibited Imch. 8. Current-voltage (I-V) curves obtained during muscarinic agonist perfusion consistently crossed the control I-V curves at a mean membrane potential of +24 mV. The reversal potential shifted to a more negative value in low extracellular Na+. 9. Although no reversal of Imch was seen when agonists were applied to cells clamped at negative holding potentials, the averaged curve of Imch, obtained by subtracting control ramp I-V curves from those obtained in the presence of agonist, did show a small net outward current at membrane potentials negative to -100 mV.(ABSTRACT TRUNCATED AT 400 WORDS)


1992 ◽  
Vol 58 ◽  
pp. 337
Author(s):  
T. Morita ◽  
G. Edwards ◽  
Th. Noack ◽  
P. Deitmer ◽  
A.H. Weston

1991 ◽  
Vol 193 (2) ◽  
pp. 217-222 ◽  
Author(s):  
Yasuyuki Furukawa ◽  
Kunio Akahane ◽  
Yasuhiro Ogiwara ◽  
Shigetoshi Chiba

Toxicon ◽  
1996 ◽  
Vol 34 (11-12) ◽  
pp. 1413-1419 ◽  
Author(s):  
Fernando Martinez ◽  
Baltazar Becerril ◽  
Georgina B. Gurrola ◽  
Brian M. Martin ◽  
Lourival D. Possani

2012 ◽  
Vol 363 (1) ◽  
pp. 308-319 ◽  
Author(s):  
Walter L. Eckalbar ◽  
Eris Lasku ◽  
Carlos R. Infante ◽  
Ruth M. Elsey ◽  
Glenn J. Markov ◽  
...  

1996 ◽  
Vol 315 (3) ◽  
pp. 977-981 ◽  
Author(s):  
Timoteo OLAMENDI-PORTUGAL ◽  
Froylan GÓMEZ-LAGUNAS ◽  
Georgina B. GURROLA ◽  
Lourival D. POSSANI

A novel peptide was purified and characterized from the venom of the scorpion Pandinus imperator. Analysis of its primary structure reveals that it belongs to a new structural class of K+-channel blocking peptide, composed of only 35 amino acids, but cross-linked by four disulphide bridges. It is 40, 43 and 46% identical to noxiustoxin, margatoxin and toxin 1 of Centruroides limpidus respectively. However, it is less similar (26 to 37% identity) to toxins from scorpions of the geni Leiurus, Androctonus and Buthus. The disulphide pairing was determined by sequencing heterodimers produced by mild enzymic hydrolysis. They are formed between Cys-4–Cys-25, Cys-10–Cys-30, Cys-14–Cys-32 and Cys-20–Cys-35. Three-dimensional modelling, using the parameters determined for charybdotoxin, showed that is it possible to accommodate the four disulphide bridges in the same general structure of the other K+-channel blocking peptides. The new peptide (Pi1) blocks Shaker B K+ channels reversibly. It also displaces the binding of a known K+-channel blocker, [125I]noxiustoxin, from rat brain synaptosomal membranes with an IC50 of about 10 nM.


Sign in / Sign up

Export Citation Format

Share Document